These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 31911283

  • 21. Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing.
    Gilman S, Koeppe RA, Little R, An H, Junck L, Giordani B, Persad C, Heumann M, Wernette K.
    Exp Neurol; 2005 Feb; 191 Suppl 1():S95-S103. PubMed ID: 15629765
    [Abstract] [Full Text] [Related]

  • 22. Spatial metabolic profiles to discriminate dementia with Lewy bodies from Alzheimer disease.
    Iizuka T, Kameyama M.
    J Neurol; 2020 Jul; 267(7):1960-1969. PubMed ID: 32170446
    [Abstract] [Full Text] [Related]

  • 23. Spatial covariance analysis of FDG-PET and HMPAO-SPECT for the differential diagnosis of dementia with Lewy bodies and Alzheimer's disease.
    Ingram M, Colloby SJ, Firbank MJ, Lloyd JJ, O'Brien JT, Taylor JP.
    Psychiatry Res Neuroimaging; 2022 Jun; 322():111460. PubMed ID: 35247828
    [Abstract] [Full Text] [Related]

  • 24. Effect of Alzheimer's Disease and Lewy Body Disease on Metabolic Changes.
    Lee YH, Jeon S, Yoo HS, Chung SJ, Jung JH, Baik K, Sohn YH, Lee PH, Yun M, Evans AC, Ye BS.
    J Alzheimers Dis; 2021 Jun; 79(4):1471-1487. PubMed ID: 33459638
    [Abstract] [Full Text] [Related]

  • 25. Comparison of univariate and multivariate analyses for brain [18F]FDG PET data in α-synucleinopathies.
    Carli G, Meles SK, Reesink FE, de Jong BM, Pilotto A, Padovani A, Galbiati A, Ferini-Strambi L, Leenders KL, Perani D.
    Neuroimage Clin; 2023 Jun; 39():103475. PubMed ID: 37494757
    [Abstract] [Full Text] [Related]

  • 26. A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer's disease, and mild cognitive impairment using brain 18F-FDG PET.
    Etminani K, Soliman A, Davidsson A, Chang JR, Martínez-Sanchis B, Byttner S, Camacho V, Bauckneht M, Stegeran R, Ressner M, Agudelo-Cifuentes M, Chincarini A, Brendel M, Rominger A, Bruffaerts R, Vandenberghe R, Kramberger MG, Trost M, Nicastro N, Frisoni GB, Lemstra AW, van Berckel BNM, Pilotto A, Padovani A, Morbelli S, Aarsland D, Nobili F, Garibotto V, Ochoa-Figueroa M.
    Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):563-584. PubMed ID: 34328531
    [Abstract] [Full Text] [Related]

  • 27. [18F]FDG-PET study in dementia with Lewy bodies and Alzheimer's disease.
    Okamura N, Arai H, Higuchi M, Tashiro M, Matsui T, Hu XS, Takeda A, Itoh M, Sasaki H.
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Feb; 25(2):447-56. PubMed ID: 11294488
    [Abstract] [Full Text] [Related]

  • 28. Neuropathological investigation of the hypometabolic regions on positron emission tomography with [18F] fluorodeoxyglucose in patients with dementia with Lewy bodies.
    Kasanuki K, Iseki E, Fujishiro H, Yamamoto R, Higashi S, Minegishi M, Togo T, Katsuse O, Uchikado H, Furukawa Y, Hino H, Kosaka K, Sato K, Arai H.
    J Neurol Sci; 2012 Mar 15; 314(1-2):111-9. PubMed ID: 22041339
    [Abstract] [Full Text] [Related]

  • 29. Early differential diagnosis between Alzheimer's disease and dementia with Lewy bodies: Comparison between (18)F-FDG PET and (123)I-IMP SPECT.
    Chiba Y, Iseki E, Fujishiro H, Ota K, Kasanuki K, Suzuki M, Hirayasu Y, Arai H, Sato K.
    Psychiatry Res Neuroimaging; 2016 Mar 30; 249():105-12. PubMed ID: 26857415
    [Abstract] [Full Text] [Related]

  • 30. Differentiating Mild Cognitive Impairment, Alzheimer's Disease, and Dementia With Lewy Bodies Using Cingulate Island Sign on Perfusion IMP-SPECT.
    Kanetaka H, Shimizu S, Inagawa Y, Hirose D, Takenoshita N, Sakurai H, Hanyu H.
    Front Neurol; 2020 Mar 30; 11():568438. PubMed ID: 33329310
    [Abstract] [Full Text] [Related]

  • 31. Characteristics of amnestic patients with hypometabolism patterns suggestive of Lewy body pathology.
    Silva-Rodríguez J, Labrador-Espinosa MA, Moscoso A, Schöll M, Mir P, Grothe MJ, Alzheimer’s Disease Neuroimaging Initiative.
    Brain; 2023 Nov 02; 146(11):4520-4531. PubMed ID: 37284793
    [Abstract] [Full Text] [Related]

  • 32. Fully automatic differential diagnosis system for dementia with Lewy bodies and Alzheimer's disease using FDG-PET and 3D-SSP.
    Kono AK, Ishii K, Sofue K, Miyamoto N, Sakamoto S, Mori E.
    Eur J Nucl Med Mol Imaging; 2007 Sep 02; 34(9):1490-7. PubMed ID: 17318545
    [Abstract] [Full Text] [Related]

  • 33. Distinguishing between dementia with Lewy bodies and Alzheimer's disease using metabolic patterns.
    Ye BS, Lee S, Yoo H, Chung SJ, Lee YH, Choi Y, Lee PH, Sohn YH, Yun M.
    Neurobiol Aging; 2020 Mar 02; 87():11-17. PubMed ID: 31791660
    [Abstract] [Full Text] [Related]

  • 34. [Cingulate Island Sign].
    Imabayashi E.
    Brain Nerve; 2018 Aug 02; 70(8):879-888. PubMed ID: 30082498
    [Abstract] [Full Text] [Related]

  • 35. Neuropathological Changes in Dementia With Lewy Bodies and the Cingulate Island Sign.
    Patterson L, Firbank MJ, Colloby SJ, Attems J, Thomas AJ, Morris CM.
    J Neuropathol Exp Neurol; 2019 Aug 01; 78(8):717-724. PubMed ID: 31271438
    [Abstract] [Full Text] [Related]

  • 36. Syndrome-specific patterns of regional cerebral glucose metabolism in posterior cortical atrophy in comparison to dementia with Lewy bodies and Alzheimer's disease--a [F-18]-FDG pet study.
    Spehl TS, Hellwig S, Amtage F, Weiller C, Bormann T, Weber WA, Hüll M, Meyer PT, Frings L.
    J Neuroimaging; 2015 Aug 01; 25(2):281-288. PubMed ID: 24593796
    [Abstract] [Full Text] [Related]

  • 37. Two distinct pathological substrates associated with MMSE-pentagons item deficit in DLB and AD.
    Beretta L, Caminiti SP, Santangelo R, Magnani G, Ferrari-Pellegrini F, Caffarra P, Perani D.
    Neuropsychologia; 2019 Oct 01; 133():107174. PubMed ID: 31446008
    [Abstract] [Full Text] [Related]

  • 38. Dementia with Lewy bodies can be well-differentiated from Alzheimer's disease by measurement of brain acetylcholinesterase activity-a [11C]MP4A PET study.
    Shimada H, Hirano S, Sinotoh H, Ota T, Tanaka N, Sato K, Yamada M, Fukushi K, Irie T, Zhang MR, Higuchi M, Kuwabara S, Suhara T.
    Int J Geriatr Psychiatry; 2015 Nov 01; 30(11):1105-13. PubMed ID: 26280153
    [Abstract] [Full Text] [Related]

  • 39. Characteristics of mild cognitive impairment tending to convert into Alzheimer's disease or dementia with Lewy bodies: A follow-up study in a memory clinic.
    Kondo D, Ota K, Kasanuki K, Fujishiro H, Chiba Y, Murayama N, Sato K, Hirayasu Y, Arai H, Iseki E.
    J Neurol Sci; 2016 Oct 15; 369():102-108. PubMed ID: 27653873
    [Abstract] [Full Text] [Related]

  • 40. 18F-fluorodeoxyglucose positron emission tomography in dementia with Lewy bodies.
    Graff-Radford J, Lesnick TG, Savica R, Chen Q, Ferman TJ, Przybelski SA, Jones DT, Senjem ML, Gunter JL, Kremers WK, Jack CR, Lowe VJ, Petersen RC, Knopman DS, Boeve BF, Murray ME, Dickson DW, Kantarci K.
    Brain Commun; 2020 Oct 15; 2(1):fcaa040. PubMed ID: 32566926
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.